2,340 Shares in Colgate-Palmolive (NYSE:CL) Acquired by SPC Financial Inc.

SPC Financial Inc. bought a new stake in shares of Colgate-Palmolive (NYSE:CL) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 2,340 shares of the company’s stock, valued at approximately $227,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of CL. E Fund Management Hong Kong Co. Ltd. purchased a new stake in Colgate-Palmolive during the second quarter valued at $25,000. Core Wealth Advisors Inc. lifted its stake in shares of Colgate-Palmolive by 56.6% in the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock worth $32,000 after purchasing an additional 146 shares during the period. Rise Advisors LLC purchased a new position in shares of Colgate-Palmolive in the first quarter worth approximately $38,000. Continuum Advisory LLC grew its position in Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after buying an additional 125 shares during the period. Finally, Voisard Asset Management Group Inc. purchased a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $40,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Down 1.4 %

Shares of Colgate-Palmolive stock opened at $102.31 on Wednesday. The firm’s 50 day simple moving average is $103.48 and its two-hundred day simple moving average is $96.62. The firm has a market capitalization of $83.94 billion, a price-to-earnings ratio of 32.38, a PEG ratio of 3.62 and a beta of 0.40. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $109.30. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The firm had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. Colgate-Palmolive’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.77 earnings per share. Analysts predict that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.95%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, EVP Gregory Malcolm sold 10,533 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the completion of the transaction, the executive vice president now directly owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock worth $4,486,063 in the last three months. Company insiders own 0.34% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their price objective for the company from $107.00 to $109.00 in a research report on Monday, September 9th. Barclays increased their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. Hsbc Global Res cut shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. TD Cowen upped their price target on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Tuesday, July 30th. Finally, Citigroup increased their price objective on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $104.74.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.